Role of RUNX1 rearrangements in triple-negative breast cancer progression and immune evasion

Ended Project Grant Awarded Last action

Award ID
W81XWH2211037
Recipient
Awarding agency
Obligated
$531,300

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Edison, NJ 08837, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Role of core-binding factor rearrangements in triple-negative breast cancer progression and immune evasion 1. Extends the POP by 12 months. Technical and… $0
Original award $531,300

Quick answers

Who received award W81XWH2211037?

W81XWH2211037 was awarded to HMH Hospitals Corporation by Defense Health Agency (Department of Defense) on September 15, 2022.

How much is award W81XWH2211037 worth?

$531,300 has been obligated on W81XWH2211037.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login